PCRonline

Practical considerations and procedural efficiency in intermediate-risk patients

Chairpersons: S.J.D. BRECKER, C. TAMBURINO

Objectives:

To explore different approaches in treating intermediate risk patients
To learn from the experience of large centres on how to successfully optimise TAVI procedure
To learn how to customise your strategy to each TAVI patient, and discover design features and indication of Evolut R 34mm to treat large anatomies

Lectures

Session objectives

S.J.D. Brecker

LIVE demonstration from Clinique Pasteur - Toulouse, France


A different approach into procedural risk management with intermediate risk patients

N. Van Mieghem

Practical recommendation to optimise TAVI: experience from a high volume centre

M. Abdel-Wahab

Tailoring your approach to optimise outcomes for lower risk patients - including a highlight on the new Evolut R 34mm for large annuli

J.J. Popma

Session evaluation and key learnings

C. Tamburino

Share

More from Medtronic

Visit website